Cargando…

Sensitive detection of PD-L1 expression on circulating epithelial tumor cells (CETCs) could be a potential biomarker to select patients for treatment with PD-1/PD-L1 inhibitors in early and metastatic solid tumors

BACKGROUND: The current cancer research strongly focuses on immune therapies, where the PD-1, with its ligands plays an important role. It is known that PD-L1 is frequently up-regulated in a number of different cancers and the relevance of this pathway has been extensively studied and therapeutic ap...

Descripción completa

Detalles Bibliográficos
Autores principales: Schott, Dorothea Sonja, Pizon, Monika, Pachmann, Ulrich, Pachmann, Katharina
Formato: Online Artículo Texto
Lenguaje:English
Publicado: Impact Journals LLC 2017
Materias:
Acceso en línea:https://www.ncbi.nlm.nih.gov/pmc/articles/PMC5641167/
https://www.ncbi.nlm.nih.gov/pubmed/29069824
http://dx.doi.org/10.18632/oncotarget.20346